193 related articles for article (PubMed ID: 32208128)
21. Pegylated arginine deiminase treatment of patients with unresectable hepatocellular carcinoma: results from phase I/II studies.
Izzo F; Marra P; Beneduce G; Castello G; Vallone P; De Rosa V; Cremona F; Ensor CM; Holtsberg FW; Bomalaski JS; Clark MA; Ng C; Curley SA
J Clin Oncol; 2004 May; 22(10):1815-22. PubMed ID: 15143074
[TBL] [Abstract][Full Text] [Related]
22. Purification, immobilization, and biochemical characterization of l-arginine deiminase from thermophilic Aspergillus fumigatus KJ434941: anticancer activity in vitro.
El-Sayed AS; Hassan MN; Nada HM
Biotechnol Prog; 2015; 31(2):396-405. PubMed ID: 25582958
[TBL] [Abstract][Full Text] [Related]
23. Regression of hepatocellular cancer in a patient treated with arginine deiminase.
Curley SA; Bomalaski JS; Ensor CM; Holtsberg FW; Clark MA
Hepatogastroenterology; 2003; 50(53):1214-6. PubMed ID: 14571701
[TBL] [Abstract][Full Text] [Related]
24. Selective Intracellular Delivery of Recombinant Arginine Deiminase (ADI) Using pH-Sensitive Cell Penetrating Peptides To Overcome ADI Resistance in Hypoxic Breast Cancer Cells.
Yeh TH; Chen YR; Chen SY; Shen WC; Ann DK; Zaro JL; Shen LJ
Mol Pharm; 2016 Jan; 13(1):262-71. PubMed ID: 26642391
[TBL] [Abstract][Full Text] [Related]
25. Arginine Deiminase Enzyme Evolving as a Potential Antitumor Agent.
Somani RR; Chaskar PK
Mini Rev Med Chem; 2018; 18(4):363-368. PubMed ID: 27538511
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic evaluation of L-arginine catabolic pathways in 24 cyanobacteria and transcriptional analysis of genes encoding enzymes of L-arginine catabolism in the cyanobacterium Synechocystis sp. PCC 6803.
Schriek S; Rückert C; Staiger D; Pistorius EK; Michel KP
BMC Genomics; 2007 Nov; 8():437. PubMed ID: 18045455
[TBL] [Abstract][Full Text] [Related]
27. Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation.
Singh PK; Deorukhkar AA; Venkatesulu BP; Li X; Tailor R; Bomalaski JS; Krishnan S
Mol Cancer Ther; 2019 Dec; 18(12):2381-2393. PubMed ID: 31395686
[TBL] [Abstract][Full Text] [Related]
28. Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion.
Cheng PN; Lam TL; Lam WM; Tsui SM; Cheng AW; Lo WH; Leung YC
Cancer Res; 2007 Jan; 67(1):309-17. PubMed ID: 17210712
[TBL] [Abstract][Full Text] [Related]
29. Prediction of the structure and function of AstA and AstB, the first two enzymes of the arginine succinyltransferase pathway of arginine catabolism.
Shirai H; Mizuguchi K
FEBS Lett; 2003 Dec; 555(3):505-10. PubMed ID: 14675764
[TBL] [Abstract][Full Text] [Related]
30. Arginine deprivation in cancer therapy.
Feun LG; Kuo MT; Savaraj N
Curr Opin Clin Nutr Metab Care; 2015 Jan; 18(1):78-82. PubMed ID: 25474015
[TBL] [Abstract][Full Text] [Related]
31. Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma.
Glazer ES; Piccirillo M; Albino V; Di Giacomo R; Palaia R; Mastro AA; Beneduce G; Castello G; De Rosa V; Petrillo A; Ascierto PA; Curley SA; Izzo F
J Clin Oncol; 2010 May; 28(13):2220-6. PubMed ID: 20351325
[TBL] [Abstract][Full Text] [Related]
32. Evaluating Five Escherichia coli Derivative Strains as a Platform for Arginine Deiminase Overproduction.
Abdollahi S; Morowvat MH; Savardashtaki A; Irajie C; Najafipour S; Ghasemi Y
Recent Pat Biotechnol; 2022; 16(2):174-183. PubMed ID: 34809551
[TBL] [Abstract][Full Text] [Related]
33. Expression and Characterization of Serotype 2 Streptococcus suis Arginine Deiminase.
Maneerat K; Yongkiettrakul S; Jiemsup S; Tongtawe P; Gottschalk M; Srimanote P
J Mol Microbiol Biotechnol; 2017; 27(3):133-146. PubMed ID: 28456803
[TBL] [Abstract][Full Text] [Related]
34. Arginine deiminase resistance in melanoma cells is associated with metabolic reprogramming, glucose dependence, and glutamine addiction.
Long Y; Tsai WB; Wangpaichitr M; Tsukamoto T; Savaraj N; Feun LG; Kuo MT
Mol Cancer Ther; 2013 Nov; 12(11):2581-90. PubMed ID: 23979920
[TBL] [Abstract][Full Text] [Related]
35. Gene structure, organization, expression, and potential regulatory mechanisms of arginine catabolism in Enterococcus faecalis.
Barcelona-Andrés B; Marina A; Rubio V
J Bacteriol; 2002 Nov; 184(22):6289-300. PubMed ID: 12399499
[TBL] [Abstract][Full Text] [Related]
36. Activation of Ras/PI3K/ERK pathway induces c-Myc stabilization to upregulate argininosuccinate synthetase, leading to arginine deiminase resistance in melanoma cells.
Tsai WB; Aiba I; Long Y; Lin HK; Feun L; Savaraj N; Kuo MT
Cancer Res; 2012 May; 72(10):2622-33. PubMed ID: 22461507
[TBL] [Abstract][Full Text] [Related]
37. Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target.
Galkin A; Kulakova L; Sarikaya E; Lim K; Howard A; Herzberg O
J Biol Chem; 2004 Apr; 279(14):14001-8. PubMed ID: 14701825
[TBL] [Abstract][Full Text] [Related]
38. Mono-PEGylation of a Thermostable Arginine-Depleting Enzyme for the Treatment of Lung Cancer.
Chung SF; Kim CF; Kwok SY; Tam SY; Chen YW; Chong HC; Leung SL; So PK; Wong KY; Leung YC; Lo WH
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545874
[TBL] [Abstract][Full Text] [Related]
39. Amino Acid Uptake Measured by [
Prudner BC; Sun F; Kremer JC; Xu J; Huang C; Sai KKS; Morgan Z; Leeds H; McConathy J; Van Tine BA
Theranostics; 2018; 8(8):2107-2116. PubMed ID: 29721066
[No Abstract] [Full Text] [Related]
40. Arginine deiminase expressed in vivo, driven by human telomerase reverse transcriptase promoter, displays high hepatoma targeting and oncolytic efficiency.
Jiang H; Guo S; Xiao D; Bian X; Wang J; Wang Y; Zhou H; Cai J; Zheng Z
Oncotarget; 2017 Jun; 8(23):37694-37704. PubMed ID: 28455966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]